Cannabis-Induced Psychosis Shows Less Cognitive Damage Than Schizophrenia

Patients with cannabis-induced psychosis performed significantly better on tests of intelligence and attention than patients with schizophrenia who also used cannabis, despite similar cannabis exposure patterns.

Shah, Raghav et al.·International journal of psychiatry in clinical practice·2021·Preliminary EvidenceCross-Sectional
RTHC-03517Cross SectionalPreliminary Evidence2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Cross-Sectional
Evidence
Preliminary Evidence
Sample
N=20

What This Study Found

With 20 matched participants per group, cannabis-induced psychosis patients performed significantly better than schizophrenia-with-cannabis patients on general intelligence and attention tests, and showed cognitive deficits only in some executive function domains compared to healthy controls.

Key Numbers

20 participants per group (60 total); no significant differences in cannabis exposure between CIP and SZC groups; CIP performed significantly better than SZC on intelligence and attention; SZC impaired on all cognitive domains vs controls; CIP impaired only on some executive function domains vs controls.

How They Did This

Cross-sectional study comparing 20 cannabis-induced psychosis patients, 20 schizophrenia-with-cannabis patients, and 20 healthy controls matched on age, education, and handedness, using standardized neurocognitive batteries.

Why This Research Matters

If cannabis-induced psychosis and schizophrenia produce different cognitive profiles despite similar cannabis exposure, it suggests they may be distinct conditions with different underlying neurobiology rather than points on a single spectrum.

The Bigger Picture

The cognitive distinction between these two conditions supports the clinical importance of distinguishing cannabis-induced psychosis from schizophrenia with concurrent cannabis use, as the prognosis and treatment approach may differ.

What This Study Doesn't Tell Us

Small sample size (20 per group); cross-sectional design; diagnostic distinction between CIP and SZC can be clinically challenging; results may not generalize across populations.

Questions This Raises

  • ?Do the cognitive differences between CIP and SZC persist long-term?
  • ?Would neuroimaging show corresponding structural differences between these groups?

Trust & Context

Key Stat:
Cannabis-induced psychosis patients performed significantly better on intelligence and attention than schizophrenia patients with similar cannabis use
Evidence Grade:
Small cross-sectional study with matched groups, limited by sample size and the inherent difficulty of distinguishing CIP from SZC.
Study Age:
Published in 2021.
Original Title:
Do neurocognitive functions in cannabis induced psychosis groups differ from schizophrenia with cannabis use? A controlled cross-sectional study.
Published In:
International journal of psychiatry in clinical practice, 25(3), 283-291 (2021)
Database ID:
RTHC-03517

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

A snapshot of a population at one point in time.

What do these levels mean? →

Frequently Asked Questions

Is cannabis-induced psychosis the same as schizophrenia?

This study suggests not. Despite similar cannabis use patterns, patients diagnosed with cannabis-induced psychosis showed significantly better cognitive function than those with schizophrenia, particularly in intelligence and attention.

How do doctors tell them apart?

Distinguishing cannabis-induced psychosis from schizophrenia with cannabis use remains a clinical challenge. This study suggests neurocognitive testing could help, as the conditions showed different cognitive profiles.

Read More on RethinkTHC

Cite This Study

RTHC-03517·https://rethinkthc.com/research/RTHC-03517

APA

Shah, Raghav; Ghosh, Abhishek; Avasthi, Ajit; Nehra, Ritu; Ahuja, Chirag K; Khandelwal, Niranjan. (2021). Do neurocognitive functions in cannabis induced psychosis groups differ from schizophrenia with cannabis use? A controlled cross-sectional study.. International journal of psychiatry in clinical practice, 25(3), 283-291. https://doi.org/10.1080/13651501.2021.1912356

MLA

Shah, Raghav, et al. "Do neurocognitive functions in cannabis induced psychosis groups differ from schizophrenia with cannabis use? A controlled cross-sectional study.." International journal of psychiatry in clinical practice, 2021. https://doi.org/10.1080/13651501.2021.1912356

RethinkTHC

RethinkTHC Research Database. "Do neurocognitive functions in cannabis induced psychosis gr..." RTHC-03517. Retrieved from https://rethinkthc.com/research/shah-2021-do-neurocognitive-functions-in

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.